Note: the following material is for personal use only see below for


Pseudorheumatoid arthritis (Type B)



Download 3.95 Mb.
Page5/73
Date30.04.2018
Size3.95 Mb.
#47014
1   2   3   4   5   6   7   8   9   ...   73

Pseudorheumatoid arthritis (Type B)


10% with low titre RF / joints inflamed “out of phase” (like gout, not like RA), osteophytes, CPPD, lack of typical erosion patterns on X-ray

can mimic sepsis in elderly patients (fever, WBCs, mental status, polyarthritis)


Hydroxyapatite (HA)

secondary to many systemic disease states (apparently, mostly with elevated Ca2+) / crystals so small, a special stain is required to detect / anti-inflammatory treatment may shorten duration of attacks, long-term changes cannot be undone?


Calcium oxalate (CaOx)

strong positive (+) birefringence

Primary: rare genetic disorder, death < 20 yrs

Secondary: renal failure or vitamin C abuse


Fibromyalgia

usu. middle-aged women / hypersensitivity to physical stimulation causing pain, fatigue, poor sleep(mechanism poorly understood)



Diagnosis: diagnosis by exclusion of other disorders and demonstrating ≥ 11 of 18 trigger points

Labs: no specific lab abnormalities

Treatment: no good treatment, but TCA’s might provide some relief

Relapsing polychondritis


Inflammation of cartilage (breakdown of chondroitin sulfate)

Findings: saddle-nose deformity, scleral thinning (scleromalacia), floppy ear, aneurysms, valvular insufficiency (AR, MR, TR), tracheal narrowing (steeple sign)
Liquid lipid microspherules?
Other Bone Disorders
Scoliosis

adolescent females > males / 20% with positive family history


slipped capital femoral epiphyses

20% with referred knee pain (can be misleading) / occurs in pubescent males, happens gradually, can be bilateral / Treatment: surgical with pinning


Villonodular synovitis (benign neoplasms)

aggregates of polyhedral cells, hemosiderin, foam cells, giant cells, zones of sclerosis

Treatment: surgery if possible, usually difficult to excise
pigmented villonodular synovitis (PVNS)

single or multiple, diffuse involvement, red-brown projections


giant cell tumor of tendon sheath (localized tenosynovitis)

small, discrete nodule


Bone Cancer
mets most common form: BLT2KP lung > breast (lytic) > prostate (blastic) > testes, kidney

primary malignant: OS, malignant fibrous histiocytoma, adamantinoma, chordoma


Osteochondroma

most common primary bone lesion / young males / sessile or stalked / cartilage cap / usually stops growing as bones mature
Chondroma

single or multiple (Olier’s Disease, Maffucci’s syndrome) / short bones of hands, feet / radiolucent [XR] / lobulated, hypercellular, disorganized / focal calcification w/in lesion / self-limited disease


Chondrosarcoma - good prognosis

proliferation of malignant cartilage / older males / axial skeleton / surgery only useful option


Osteoid osteoma

very common / young males / < 2 cm growth / appendicular skeleton / produces pain at night (relieved by aspirin) / radiolucent lesion surround by reactive bone formation / surgical removal / 25% relapse due to poor nidus locating by surgeon


Osteosarcoma (OS) - poor prognosis

pre-op and post-op chemotherapy / arm, leg bones / produces bone, cartilage, spindle cells usually have mets / cortical destruction w/ extension in soft tissues (Codman’s triangle)


Parosteal osteosarcoma (POS) - excellent prognosis

young, early middle age, women / long bones / radiolucent ‘string sign’ along cortex / spindle cells produce well-formed bone


Ewing’s sarcoma (variable prognosis)

small cell neoplasia / unknown histiogenesis / very young, males, lower extremities / XR: moth-eaten intramedullary pattern, ‘onion skin’ periosteal reactive bone / diaphysis to metaphysis / PAS+ cytoplasm / therapy evolving


Fibrous cortical defect

very common / young, males, long bones / XR: metaphysis, sub-cortical, soap bubbles, sclerosis at interface spindle cells, foamy macrophages, hemosiderin, chronic infiltrate / self-limiting at skeletal maturity


Fibrous dysplasia

very common / single, multiple / young, localization random / XR: radiopaque, ‘shepherd’s crook’ of proximal femur / spindle, cells, woven bone, lack of osteoblastic rimming, Chinese character appearance / no treatment unless symptomatic / excellent prognosis


Malignant fibrous histiocytoma (poor prognosis)

similar demographics to OS / XR: metaphysis, destructive, radiolucent / anaplastic spindle cells, storiform pattern / treatment same and prognosis slightly worse than OS


Giant cell tumor of bone

benign but aggressive local tumor / young, wide distribution / hemorrhage / surgery when possible / extended curettage (experimental) or resection / prosthesis / 98% monostotic / radiation contraindicated (secondary sarcomas)


Adamantinoma (good prognosis)

primary malignant bone tumor / young males, tibia/fibula / XR: may be multifocal (observe carefully) / epithelial or endothelial proliferation / complete surgical extirpation


Chordoma

malignant bone tumor arising from notochord / 40s to 60s / males / physaliferous cells in acid mucoid background / surgery and post-op radiation

survival: sacral 60% (fair) 5 yr, cervical (horrible) 50% 5 yr 0% 8 yr
Myositis ossificans

athletic adolescents, history of trauma (50%) / central fibroblast proliferation, intermediate zone of osteoid formation, peripheral shell of organized bone / Treatment: usually cured by excision
Connective Tissue Diseases
Rheumatoid arthritis (see bone)
Systemic Lupus Erythematosis (SLE)

1 in 300 black women / HLA-DR3 / HLA-DR2



Differential: psoriasis (i.e. avoid UV light therapy), lyme disease, drug reactions, tinea

Diagnosis: must meet 4 of 11 criteria (malar rash, discoid rash, photosensitivity, mucosal

ulcers, arthritis, serositis, renal, neurologic, hematologic, positive ANA, positive LE or anti-ds or anti-Sm)



Complications:

General: fatigue, weight loss, fever

Skin: malar rash (fixed erythema, flat or raised over malar area, tends to spare nasolabial folds), discoid rash (erythematous raised patches with adherent keratotic scaling and follicular plugging), photosensitivity, periungual telangiectasia, alopecia

Renal: many forms possible / note: 80-90% of SLE becomes dormant when ESRD occurs

  • mesangial (earliest: may remit or transition to other forms)

  • focal proliferative (50%)

  • membranous (50%)

  • diffuse proliferative (20%, worst)

Cardiovascular:

  • endocarditis (Libman-Sacks/caused by APA syndrome)

  • pericarditis

  • hypercoagulability

  • Raynaud’s (20-30%)

  • purpuric lesions (see hematologic)

Hematologic:

  • hypercoagulable state (in addition, there is arterial-specific hypercoagulability in SLE patients due to variant mannose-binding lectin genes)

  • leukopenia (<4000/mm3), lymphopenia (<1500/mm3), thrombocytopenia (<100,000/mm3), hemolytic anemia

Pulmonary:

More common  pleuritis (LE cells are very specific, WBC’s with pushed aside nucleus, very characteristic appearance, but make sure pathologist looks for them), pleural effusion (mildly exudative, unilateral or bilateral)

Less common  ILD (including pneumonitis)

PE (from APA)

pulmonary HTN

diffuse alveolar hemorrhage (rare): 90% will have concurrent nephritis, abrupt onset, young women, association with pneumonia)

malignancy: ↑ risk of lung cancer > lymphoma

other: BOOP, shrinking-lung syndrome, lymphadenopathy, infections



GI: painless oral or vaginal ulcers, non-specific abdominal complaints / GI vasculitis (less common, serious)

Musculoskeletal: arthralgias (symmetric/peripheral, two or more joints, swelling, effusion,

tenderness but NOT erosive; only small percentage actually get joint deforming arthritis as in RA)



CNS: diffuse psychosis, depression or focal neurological deficits (including seizures) [Ddx] / 50% experience some degree of neuropsychiatric problems / may see cystoid bodies in fundus

Other: hepatosplenomegaly (functional hyposplenism), LAD

Labs:

decreased C3/C4 (can be marker of active disease, either can be depressed first depending on if classical or alternate pathway is activated, can also be decreased from poor synthesis such as in liver disease)

thrombocytopenia, anemia

schistocytes generally not seen without active vasculitis or major HTN

anticardiolipin Ab (30-50% have it, fewer actually have APA syndrome)

false positive VDRL



anti-nuclear antibodies (ANA) (labs)

98% sensitivity, often high titre (1:80 happens in many people is non-specific) / 10% of SLE in whites may be ANA only (no other positive Abs), this is rare in non-whites


Specific Patterns
Peripheral  active disease, renal involvement

Diffuse  SLE, RA, discoid lupus, normal elderly (rare) / can mask speckled or peripheral pattern

Speckled  RA, SLE, MCTD, chronic discoid lupus, chronic lung disease, scleroderma, normal elderly (rare)

Nucleolar pattern  scleroderma (occasionally SLE, RA, Sjogren’s)


anti-ds DNA specific for SLE, can fluctuate with treatment

RPGN, rash, pneumonitis

anti-Sm very specific

anti-Ro (SSA) Sjogren’s, SLE, myositis, etc.

anti-La (SSB) cannot have La without Ro

anti-U1-RNP/nRNP

SLE, PSS, myositis / cytoplasmic Ab, thus can be negative ANA / very strong correlation with blacks + Raynaud’s and/or myositis and primary pulmonary HTN (uncommon)

anti-ribosomal P

specific for SLE, can be sole antibody with ANA negative SLE

ANA to histone (diffuse pattern)

suggests drug-induced (90% sensitive, but not so specific in that 20-30% of idiopathic SLE will have anti-histone Abs)
Note: each patient has there own idiosyncratic pattern of lab markers to follow (compliment, platelets, WBC?, Anti-DS)
Drug-induced SLE

SLE-like syndrome / (+) ANA to histone / (+) genetic predisposition, ANA may remain positive for years

Course: usually much less severe, resolves within 6 months of stopping drug

Drugs: procainamide, INH, hydralazine, chlorpromazine, methyldopa
Cutaneous lupus erythematosus

Pathology: interface dermatitis and granular deposition of IgG along the dermal-epidermal junction


Chronic Discoid Lupus
Chilblain’s Lupus – rare

violaceous digital plaques, nodules develop after cold exposure / anti-Ro (SSA), Raynaud’s, changes in nail-fold capillaries / lesions contain papillary and deep dermal T-cells


Pregnancy and SLE

antibodies DO cross placenta and affect infant up to 6 months after birth / can cause irreversible congenital heart block (anti-Ro/SSA) (often before mother is diagnosed)



Treatment: education! If disease is controlled (and < 10 mg prednisone), then it is okay to proceed with pregnancy
Sjögren’s syndrome (Keratoconjunctivitis Sicca) [NEJM]

females (usu. peri-menopause) / HLA-DR3 / can have primary or secondary (with SLE/RA)

Mechanism: lymphocytic infiltration and destruction of lacrimal and salivary glands

Presentation: dry eyes, dry mouth, dry skin, enlarged parotid, enlarged lacrimal gland / patient avoids sour foods

Findings: dry skin, GI, GU, arthritis (more synovitis), bronchitis

Complications:


  • Peripheral neuropathies (50-60%) / usu. pure sensory, asymmetric chronic neuropathy (may precede other symptoms by many years)

  • GERD

  • increased risk of B-cell lymphoma (1-5%)

  • association with decreased PFTs (lung disease)

Diagnosis: eye exam (Schirmer test), lip biopsy (salivary gland) in uncertain cases, SSA (anti-Ro), SSB (anti-La) occur in only 3% of cases [note, one does not have anti-SSB without anti-SSA], often have elevated RF, ESR

Treatment: symptomatic (fake tears, benzodiazepines for anxiety, etc.), pro-cholinergic agents, steroids for severe systemic complications
Polymyositis/Dermatomyositis


Download 3.95 Mb.

Share with your friends:
1   2   3   4   5   6   7   8   9   ...   73




The database is protected by copyright ©ininet.org 2024
send message

    Main page